Kinnevik AB is an institution, managing $65.6M across 1 long positions as of Q3 2025 with 100% Healthcare concentration, with only 1 position, and 100% allocation to RXRX.
Largest long holdings in Kinnevik AB's portfolio (100% of total portfolio)
| Holding | Sector | Position | Weight | Traded | Ownership |
|---|---|---|---|---|---|
Biotechnology Healthcare | $65.6M | 100.00% | — | 3.08% 13.4M shares |
Portfolio insights and performance metrics for Kinnevik AB
We use cookies for analytics. See our Privacy and Cookie Policy.